Characteristics of the env genes of HIV type 1 quasispecies in long-term nonprogressors with broadly neutralizing antibodies

被引:22
作者
Braibant, Martine [1 ]
Agut, Henri [2 ]
Rouzioux, Christine [3 ]
Costagliola, Dominique [4 ]
Autran, Brigitte [5 ]
Barin, Francis [1 ]
机构
[1] Univ Tours, Tours, France
[2] Hop La Pitie Salpetriere, Virol Lab, Paris, France
[3] Hop Necker Enfants Malad, Virol Lab, Paris, France
[4] Univ Paris 06, Paris, France
[5] Hop Pietie Salpetriere, Lab Immunol Celulaire & Tissulaire, Paris, France
关键词
neutralizing antibody; long-term nonprogressors; gp120 envelope glycoprotein;
D O I
10.1097/QAI.0b013e318162cac2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Primary isolates of different subtypes of HIV-1 can be neutralized in vitro by the broadly neutralizing antibodies (NAbs) found in the sera of a small number of HIV-1-infected patients. This broad response is most frequent in long-term nonprogressors (LTNPs). We investigated whether the presence of NAbs in the sera of some LTNPs was associated with particular properties of the envelope glycoproteins of the variants found in these patients. Toward that aim, 147 env gene fragments (encoding almost the entire gp 120) amplified from the proviral DNA of 5 LTNPs who developed broadly NAbs (NAb+) and of 4 LTNPs who did not develop such broadly NAbs (NAb-) were cloned, sequenced, and compared. We found that the development of broadly NAbs was associated with high viral loads, greater diversity in the gp120 of the viruses infecting these patients, and longer V I sequences and additional N-gly sites in VI. In addition, a higher proportion of defective clones was found among the env genes of NAb- patients (25% to 93 %)-particularly those with lower viral loads and low levels of env diversity-than among those of NAb+ patients (7% to 19%).
引用
收藏
页码:274 / 284
页数:11
相关论文
共 66 条
[21]   Evolutionary dynamics of the glycan shield of the human immunodeficiency virus envelope during natural infection and implications for exposure of the 2G12 epitope [J].
Dacheux, L ;
Moreau, A ;
Ataman-Önal, Y ;
Biron, F ;
Verrier, B ;
Barin, F .
JOURNAL OF VIROLOGY, 2004, 78 (22) :12625-12637
[22]   Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: Evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses [J].
Decks, Steven G. ;
Schweighardt, Becky ;
Wrin, Terri ;
Galovich, Justin ;
Hoh, Rebecca ;
Sinclair, Elizabeth ;
Hunt, Peter ;
McCune, Joseph M. ;
Martin, Jeffrey N. ;
Petropoulos, Christos J. ;
Hecht, Frederick M. .
JOURNAL OF VIROLOGY, 2006, 80 (12) :6155-6164
[23]   Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission [J].
Derdeyn, CA ;
Decker, JM ;
Bibollet-Ruche, F ;
Mokili, JL ;
Muldoon, M ;
Denham, SA ;
Heil, ML ;
Kasolo, F ;
Musonda, R ;
Hahn, BH ;
Shaw, GM ;
Korber, BT ;
Allen, S ;
Hunter, E .
SCIENCE, 2004, 303 (5666) :2019-2022
[24]   HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time [J].
Ghosn, J ;
Pellegrin, I ;
Goujard, C ;
Deveau, C ;
Viard, JP ;
Galimand, J ;
Harzic, M ;
Tamalet, C ;
Meyer, L ;
Rouzioux, C ;
Chaix, ML .
AIDS, 2006, 20 (02) :159-170
[25]   Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation [J].
Gonzales, MJ ;
Delwart, E ;
Rhee, SY ;
Tsui, R ;
Zolopa, AR ;
Taylor, J ;
Shafer, RW .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (03) :397-405
[26]  
HALL T. A., 1999, Nucleic Acids Symp Ser, V41, P95, DOI [10.1021/bk-1999-0734.ch008, DOI 10.1021/BK-1999-0734.CH008]
[27]   Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge [J].
Hofmann-Lehmann, R ;
Vlasak, J ;
Rasmussen, RA ;
Smith, BA ;
Baba, TW ;
Liska, V ;
Ferrantelli, F ;
Montefiori, DC ;
McClure, HM ;
Anderson, DC ;
Bernacky, BJ ;
Rizvi, TA ;
Schmidt, R ;
Hill, LR ;
Keeling, ME ;
Katinger, H ;
Stiegler, G ;
Cavacini, LA ;
Posner, MR ;
Chou, TC ;
Andersen, J ;
Ruprecht, RM .
JOURNAL OF VIROLOGY, 2001, 75 (16) :7470-7480
[28]   A patient with HIV-1 superinfection [J].
Jost, S ;
Bernard, MC ;
Kaiser, L ;
Yerly, S ;
Hirschel, B ;
Samri, A ;
Autran, B ;
Goh, LE ;
Perrin, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (10) :731-736
[30]   Clade BHIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus [J].
Koelsch, KK ;
Smith, DM ;
Little, SJ ;
Ignacio, CC ;
Macaranas, TR ;
Brown, AJL ;
Petropoulos, CJ ;
Richman, DD ;
Wong, JK .
AIDS, 2003, 17 (07) :F11-F16